Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
- PMID: 2493245
- DOI: 10.1016/0006-291x(89)92773-3
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
Erratum in
- Biochem Biophys Res Commun 1991 Jan 31;174(2):1053
Abstract
Tissue selectivity of lovastatin, simvastatin and pravastatin was determined in male rats. Peak levels of active drug were found in all tissues examined between 0.5 and 2 hours after oral administration. The area under the curve describing 24 hour exposure of the tissues to drug indicated that the drugs were preferentially concentrated in the liver. However, the concentration of pravastatin was approximately 50% that of either lovastatin or simvastatin in the liver and 3-6 times higher in peripheral tissues. These studies demonstrate that the hydrophobic prodrugs, lovastatin and simvastatin show greater selectivity than the hydrophilic agent pravastatin towards the liver which is the target organ for inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Similar articles
-
Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat.Eur J Biochem. 1992 Oct 1;209(1):315-9. doi: 10.1111/j.1432-1033.1992.tb17291.x. Eur J Biochem. 1992. PMID: 1396707
-
Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.J Lipid Res. 1989 Sep;30(9):1411-20. J Lipid Res. 1989. PMID: 2513368
-
Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.Biochim Biophys Acta. 1990 Jul 16;1045(2):115-20. doi: 10.1016/0005-2760(90)90139-o. Biochim Biophys Acta. 1990. PMID: 2116173
-
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005. Clin Pharmacokinet. 1997. PMID: 9160173 Review.
-
Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors.Pharmacol Res. 1990 Sep-Oct;22(5):555-63. doi: 10.1016/s1043-6618(05)80047-7. Pharmacol Res. 1990. PMID: 2126139 Review.
Cited by
-
Simvastatin inhibits protein isoprenylation in the brain.Neuroscience. 2016 Aug 4;329:264-74. doi: 10.1016/j.neuroscience.2016.04.053. Epub 2016 May 12. Neuroscience. 2016. PMID: 27180285 Free PMC article.
-
Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.Eur J Clin Pharmacol. 1991;40 Suppl 1:S11-4. Eur J Clin Pharmacol. 1991. PMID: 2044637 Review.
-
Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.Drugs. 1991 Jul;42(1):65-89. doi: 10.2165/00003495-199142010-00005. Drugs. 1991. PMID: 1718686 Review.
-
Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia.Br J Clin Pharmacol. 1991 Oct;32(4):417-22. doi: 10.1111/j.1365-2125.1991.tb03924.x. Br J Clin Pharmacol. 1991. PMID: 1958433 Free PMC article. Clinical Trial.
-
Pleiotropic effects of statins. - Basic research and clinical perspectives -.Circ J. 2010 May;74(5):818-26. doi: 10.1253/circj.cj-10-0110. Epub 2010 Apr 15. Circ J. 2010. PMID: 20424337 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources